trending Market Intelligence /marketintelligence/en/news-insights/trending/vra70bk7hnle4yo4fk1t_a2 content
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

In This List

Tetra Bio-Pharma completes acquisition of PhytoPain Pharma

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry


IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

The Market Intelligence Platform

Tetra Bio-Pharma completes acquisition of PhytoPain Pharma

Tetra Bio-Pharma Inc. said it completed the acquisition of the remaining 20% of PhytoPain Pharma Inc. for C$12.4 million.

The Canadian medical cannabis company paid C$248,000 in cash, C$2.2 million in promissory notes and issued 2,485,218 of its shares for the interest.